Cart
Oops, your cart is still empty
Looks like you haven’t added anything yet. Start exploring our products and find what you need.
Ipamorelin vs Hexarelin: A Complete Research Comparison
These materials are research-grade reference compounds sold for laboratory research use only. They are not for human or veterinary use.
Ipamorelin and hexarelin are both growth-hormone-releasing peptides (GHRPs) that act at the ghrelin receptor, so like GHRP-6 and GHRP-2 they belong to the same family. What makes this pair interesting is selectivity: ipamorelin was introduced specifically as a more selective secretagogue than the earlier GHRPs, and hexarelin is one of those earlier, broader-acting members. Comparing them is a way of understanding how the class was refined over time.
This article compares them in depth and strictly in research terms: their sequences, the shared receptor mechanism, the selectivity question, what the literature reports, and how each is verified and handled. Every finding is framed within its experimental context, and nothing here is guidance for human or veterinary use.
At a Glance
- Both are synthetic growth-hormone-releasing peptides studied at the ghrelin receptor (GHS-R1a).
- Ipamorelin was characterized as the first selective growth-hormone secretagogue.
- Hexarelin is an earlier GHRP-series hexapeptide studied across a range of models.
- Selectivity is the main axis of comparison between them.
- Both are research chemicals for laboratory use only, verified per lot by HPLC and mass spectrometry.
Quick Comparison
| Attribute | Ipamorelin | Hexarelin |
|---|---|---|
| Class | Growth-hormone-releasing peptide | Growth-hormone-releasing peptide |
| Receptor studied | Ghrelin receptor (GHS-R1a) | Ghrelin receptor (GHS-R1a) |
| Structure |
Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) |
Hexapeptide of the GHRP series |
| Noted feature | Selectivity in original characterization | Earlier, broader-profile GHRP |
| Comparison axis | Selectivity within the class | Selectivity within the class |
| Verification | HPLC + mass spectrometry, per-lot COA | HPLC + mass spectrometry, per-lot COA |
What Ipamorelin Is?
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). It was introduced as the first selective growth-hormone secretagogue, distinguished from earlier GHRPs by a comparatively narrow response in the models used (Raun et al., 1998). That selectivity is its defining feature in the literature and the main reason it is contrasted with earlier, broader members of the family. Exact molecular weight and purity for any lot are documented on the Certificate of Analysis.
What Hexarelin Is?
Hexarelin is a synthetic hexapeptide from the earlier GHRP series, studied at the ghrelin receptor. As one of the earlier members, it is associated in the literature with a broader profile than the later, more selective ipamorelin. It has been examined across a range of research models within the secretagogue field. Exact molecular weight and purity for any lot are documented on the Certificate of Analysis.
Selectivity as the Point of Comparison
The central theme when comparing these two is selectivity, meaning how narrowly a secretagogue acts within the growth-hormone axis in research models. Ipamorelin was specifically characterized for a narrow profile (Raun et al., 1998), while hexarelin belongs to the earlier generation that informed the pharmacology of the class (Bowers, 2012). For a researcher, selectivity affects how cleanly a study can attribute effects to the intended pathway.
What the Research Literature Reports?
Both peptides are situated in the literature as ghrelin-receptor agonists studied as growth-hormone secretagogues in animal and cell models, with ipamorelin noted for selectivity in its founding report (Raun et al., 1998) and hexarelin studied within the broader secretagogue and ghrelin-receptor framework (Bowers, 2012; Kojima et al., 1999). All findings are reported within their specific research systems and are not statements about human use.
Structure, Stability, and Research Handling
Ipamorelin is a five-residue peptide; hexarelin is a hexapeptide. Both contain non-natural residues typical of the GHRP series and are generally soluble in aqueous buffers, though behavior depends on the sequence and lot. General peptide-stability principles apply, and lot-specific stability is documented on the Certificate of Analysis rather than as a blanket duration.
How Researchers Choose Between Them
The choice usually hinges on whether a study values the narrower profile of ipamorelin or is examining the broader characteristics of an earlier GHRP such as hexarelin. Sequence, selectivity, and the depth of prior literature for the model of interest all factor in. Both act at the same receptor, so comparisons focus on their pharmacological profiles rather than their targets.
Chemical Identity and Verification
Both are verified by mass spectrometry for identity and HPLC for purity, with results on a lot-specific Certificate of Analysis. Net peptide content is distinct from chromatographic purity. Reconcile every molecular figure against the COA before use.
Storage and Handling in a Laboratory Context
Store sealed material cold, shield it from light, and avoid repeated freeze-thaw. Lyophilized material is generally more stable than material in solution. Lot-specific stability is documented on the COA.
Research Limitations and Open Questions
Both peptides are studied largely in animal and cell models, and findings do not translate directly to any human context. Direct head-to-head selectivity comparisons under identical conditions are less common than single-compound studies, so cross-study conclusions about relative selectivity should be drawn carefully.
Frequently Asked Questions
What is the difference between ipamorelin and hexarelin?
Both are GHRPs at the ghrelin receptor. Ipamorelin is described as selective in its original characterization; hexarelin is an earlier GHRP with a broader profile. They differ in sequence and selectivity.
What does selectivity mean here?
It refers to how narrowly a secretagogue acts within the growth-hormone axis in research models, as reported in the primary literature.
How do their structures compare?
Ipamorelin is a pentapeptide; hexarelin is a hexapeptide. Both contain non-natural residues typical of the GHRP series.
What research contexts is each studied in?
Both appear in secretagogue and ghrelin-receptor research in animal and cell models.
Are they interchangeable?
No. Although they share a receptor, their selectivity profiles differ, which is exactly why they are compared.
How is each verified for identity and purity?
By mass spectrometry for identity and HPLC for purity, documented on a lot-specific Certificate of Analysis.
Do these findings apply to people?
No. All cited work is in animal or cell models and describes mechanism and research outcomes only.
Related Reading
- Hexarelin reference page
- Ipamorelin reference page
- GH-Releasing Peptides (GHRP family) overview
- Lab Reports
References
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID 9849822.
- Bowers CY. History to the discovery of ghrelin. Methods Enzymol. 2012. PMID 22975043.
- Kojima M, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999. PMID 10604470.
Research-use notice: Ipamorelin and hexarelin are research chemicals sold for laboratory research use only. They are not for human or veterinary use. Every finding is reported in the specific research context of the cited study.
